A

Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia

Journal of Clinical Oncology, vol. 43, pp. 65–74

Abstract

PURPOSE To determine the optimal daunorubicin dose and number of 7 + 3 induction cycles in newly diagnosed AML, this randomized controlled trial compared a once daily dose of 60 mg/m 2 with 90 mg/m 2 daunorubicin in the first 7 + 3 induction and one versus two cycles of 7 + 3 induction. PATIENTS AND METHODS Patients age 18-65 years with newly diagnosed AML were randomly assigned to 60 versus 90 mg/m 2 daunorubicin once daily plus cytarabine. Patients with marrow blasts below 5% on day 15 after first induction were randomly assigned to receive a second induction cycle or no second induction cycle. RESULTS Eight hundred and sixty-four patients with a median age of 52 years were randomly assigned. After a preplanned interim analysis showing no significant difference in response between 60 and 90 mg/m 2 , all consecutive patients received 60 mg/m 2 daunorubicin once daily. The proportion of good early responders was 44% versus 48% ( P = .983) with a composite complete remission (CRc) rate of 90% versus 89% after induction ( P = .691); the 3-year relapse-free survival (RFS) after 60 versus 90 mg/m 2 once daily was 54% versus 50% ( P = .561), and the 3-year overall survival (OS) was 65% versus 58% ( P = .242). Among 389 good responders, CRc rates at the end of induction were 87% after single induction and 85% after double induction. The 3-year RFS was 51% versus 60% (hazard ratio [HR], 1.3; P = .091), and the 3-year OS was 76% versus 75% after single versus double induction (HR, 1.0; P = .937). CONCLUSION The use of 90 mg/m 2 daunorubicin once daily in the context of classical 7 + 3 induction does not significantly improve early response and does not lead to higher remission rates or longer survival than 60 mg/m 2 once daily. In patients with a good early response after first induction, a second induction has only a limited impact on RFS and does not result in an OS benefit.

Authors 43

  1. Technische Universität Dresden

    Affiliation as printed

    Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

  2. University Hospital Frankfurt

    Affiliation as printed

    Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany

  3. University Hospital Münster

    Affiliation as printed

    Department of Medicine A, University Hospital Münster, Münster, Germany

  4. University Hospital Münster

    Affiliation as printed

    Department of Medicine A, University Hospital Münster, Münster, Germany

  5. Technische Universität Dresden

    Affiliation as printed

    Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

  6. Klinikum Chemnitz

    Affiliation as printed

    Department of Internal Medicine III, Chemnitz Hospital, Chemnitz, Germany

  7. Klinikum Chemnitz

    Affiliation as printed

    Department of Internal Medicine III, Chemnitz Hospital, Chemnitz, Germany

  8. Essen University Hospital · University of Duisburg-Essen

    Affiliation as printed

    Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

  9. Essen University Hospital · University of Duisburg-Essen

    Affiliation as printed

    Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

  10. Robert Bosch Hospital

    Affiliation as printed

    Department of Hematology, Robert-Bosch-Krankenhaus, Stuttgart, Germany

  11. University Hospital Brno

    Affiliation as printed

    Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic

  12. Nuremberg Hospital · Paracelsus Medizinische Privatuniversität

    Affiliation as printed

    Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany

  13. Heidelberg University

    Affiliation as printed

    Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

  14. Universitätsklinikum Gießen und Marburg

    Affiliation as printed

    Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany

  15. Universitätsklinikum Gießen und Marburg

    Affiliation as printed

    Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany

  16. University Hospital Schleswig-Holstein

    Affiliation as printed

    Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  17. Institute of Haematology and Blood Transfusion

    Affiliation as printed

    Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  18. RWTH Aachen University · Universitätsklinikum Aachen

    Affiliation as printed

    Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital Aachen & CIO ABCD Aachen, RWTH Aachen, Aachen, Germany

    Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital Aachen & CIO ABCD Aachen, RWTH Aachen, Aachen, Germany

  19. Gemeinschaftsklinikum Mittelrhein

    Affiliation as printed

    Department of Hematology, Oncology and Palliative Care, Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany

  20. Universitätsklinikum Erlangen

    Affiliation as printed

    Department of Internal Medicine V, Universitätsklinikum Erlangen, Erlangen, Germany

  21. Jena University Hospital

    Affiliation as printed

    Klinik für Innere Medizin, Universitätsklinikum Jena, Jena, Germany

  22. Jena University Hospital

    Affiliation as printed

    Klinik für Innere Medizin, Universitätsklinikum Jena, Jena, Germany

  23. Westpfalz Klinikum

    Affiliation as printed

    Klinik für Innere Medizin 1, Westpfalzklinikum, Kaiserslautern, Germany

  24. Palacký University Olomouc

    Affiliation as printed

    Department of Hemato-Oncology, Palacký University, Olomouc, Czech Republic

  25. University Hospital Augsburg

    Affiliation as printed

    II. Medizinische Klinik, Universitätsklinikum Augsburg, Augsburg, Germany

  26. University Hospital Augsburg

    Affiliation as printed

    II. Medizinische Klinik, Universitätsklinikum Augsburg, Augsburg, Germany

  27. University Hospital Schleswig-Holstein

    Affiliation as printed

    Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  28. Heidelberg University · German Cancer Research Center · National Center for Tumor Diseases · Medizinische Fakultät Mannheim · University Hospital Leipzig · Leipzig University

    Affiliation as printed

    Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany

    Insitute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

    NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany

  29. Rems-Murr-Klinikum

    Affiliation as printed

    Department of Hematology, Oncology and Palliative Care, Rems-Murr-Kliniken, Winnenden, Germany

  30. Technische Universität Dresden

    Affiliation as printed

    Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

  31. Technische Universität Dresden

    Affiliation as printed

    Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

  32. Technische Universität Dresden

    Affiliation as printed

    Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

  33. Technische Universität Dresden

    Affiliation as printed

    Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

  34. Technische Universität Dresden

    Affiliation as printed

    Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

  35. University Hospital Schleswig-Holstein

    Affiliation as printed

    Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  36. University Hospital Leipzig · Leipzig University

    Affiliation as printed

    Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany

  37. Technische Universität Dresden

    Affiliation as printed

    Agendix GmbH, Dresden, Germany

    Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

  38. Heidelberg University

    Affiliation as printed

    Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

  39. University Hospital Münster

    Affiliation as printed

    Department of Medicine A, University Hospital Münster, Münster, Germany

  40. Technische Universität Dresden

    Affiliation as printed

    Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

  41. University Hospital Brno

    Affiliation as printed

    Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic

  42. University Hospital Frankfurt

    Affiliation as printed

    Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany

  43. Technische Universität Dresden

    Affiliation as printed

    Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

Cited by 16 stored of 16

16 results

No patents citing this paper on Lens.org (checked 2026-10-06).

References 23